Create Medic Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	13,761	13,617	13,030	12,585	12,257	11,698
Revenue Growth (YoY)	3.67%	4.50%	3.54%	2.68%	4.78%	8.02%
Cost of Revenue	7,802	7,624	7,326	7,107	6,883	6,438
Gross Profit	5,959	5,993	5,704	5,478	5,374	5,260
Selling, General & Admin	5,036	4,988	5,011	4,675	4,636	4,393
Operating Expenses	5,036	4,988	5,011	4,675	4,636	4,393
Operating Income	923	1,005	693	803	738	867
Interest Expense	-4	-7	-10	-10	-7	-6
Interest & Investment Income	34	35	42	35	42	43
Currency Exchange Gain (Loss)	-27	-55	3	26	26	84
Other Non Operating Income (Expenses)	17	10	23	23	11	26
EBT Excluding Unusual Items	943	988	751	877	810	1,014
Gain (Loss) on Sale of Investments	-	-	-29	-24	-	-75
Gain (Loss) on Sale of Assets	-1	-30	297	-5	4	-5
Asset Writedown	-	-123	-23	-	-	-
Other Unusual Items	45	225	89	56	22	31
Pretax Income	987	1,060	1,085	904	836	965
Income Tax Expense	330	347	245	750	376	305
Net Income	657	713	840	154	460	660
Net Income to Common	657	713	840	154	460	660
Net Income Growth	-33.64%	-15.12%	445.46%	-66.52%	-30.30%	0.15%
Shares Outstanding (Basic)	8	8	9	9	9	9
Shares Outstanding (Diluted)	9	9	9	9	9	9
Shares Change (YoY)	3.58%	0.29%	-3.17%	0.05%	0.03%	-1.83%
EPS (Basic)	78.12	84.17	95.31	16.92	50.56	72.57
EPS (Diluted)	73.07	80.75	95.31	16.92	50.56	72.57
EPS Growth	-35.86%	-15.27%	463.32%	-66.54%	-30.33%	2.02%
Free Cash Flow	-	115	1,865	263	201	949
Free Cash Flow Per Share	-	13.01	211.60	28.89	22.09	104.34
Dividend Per Share	45.000	45.000	37.000	37.000	37.000	37.000
Dividend Growth	21.62%	21.62%	-	-	-	-
Gross Margin	43.30%	44.01%	43.78%	43.53%	43.84%	44.96%
Operating Margin	6.71%	7.38%	5.32%	6.38%	6.02%	7.41%
Profit Margin	4.77%	5.24%	6.45%	1.22%	3.75%	5.64%
Free Cash Flow Margin	-	0.84%	14.31%	2.09%	1.64%	8.11%
EBITDA	1,477	1,575	1,329	1,391	1,338	1,329
EBITDA Margin	10.73%	11.57%	10.20%	11.05%	10.92%	11.36%
D&A For EBITDA	553.5	570	636	588	600	462
EBIT	923	1,005	693	803	738	867
EBIT Margin	6.71%	7.38%	5.32%	6.38%	6.02%	7.41%
Effective Tax Rate	33.43%	32.74%	22.58%	82.97%	44.98%	31.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.